290 related articles for article (PubMed ID: 15504964)
1. Pioglitazone reduces islet triglyceride content and restores impaired glucose-stimulated insulin secretion in heterozygous peroxisome proliferator-activated receptor-gamma-deficient mice on a high-fat diet.
Matsui J; Terauchi Y; Kubota N; Takamoto I; Eto K; Yamashita T; Komeda K; Yamauchi T; Kamon J; Kita S; Noda M; Kadowaki T
Diabetes; 2004 Nov; 53(11):2844-54. PubMed ID: 15504964
[TBL] [Abstract][Full Text] [Related]
2. PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress.
Kono T; Ahn G; Moss DR; Gann L; Zarain-Herzberg A; Nishiki Y; Fueger PT; Ogihara T; Evans-Molina C
Mol Endocrinol; 2012 Feb; 26(2):257-71. PubMed ID: 22240811
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis with relation to increased expression of peroxisome proliferator-activated receptor-γ in insulin resistant mice.
Satoh H; Ide N; Kagawa Y; Maeda T
Biol Pharm Bull; 2013; 36(4):616-23. PubMed ID: 23386130
[TBL] [Abstract][Full Text] [Related]
6. Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content.
Balasubramanian R; Gerrard J; Dalla Man C; Firbank MJ; Lane A; English PT; Cobelli C; Taylor R
Diabet Med; 2010 Feb; 27(2):150-6. PubMed ID: 20546257
[TBL] [Abstract][Full Text] [Related]
7. Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
Yajima K; Hirose H; Fujita H; Seto Y; Fujita H; Ukeda K; Miyashita K; Kawai T; Yamamoto Y; Ogawa T; Yamada T; Saruta T
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E966-71. PubMed ID: 12676649
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
[TBL] [Abstract][Full Text] [Related]
9. Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression.
Xiong J; Sun P; Wang Y; Hua X; Song W; Wang Y; Wu J; Yu W; Liu G; Chen L
Diabetologia; 2020 Feb; 63(2):338-350. PubMed ID: 31776610
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
[TBL] [Abstract][Full Text] [Related]
11. PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells.
Nakamichi Y; Kikuta T; Ito E; Ohara-Imaizumi M; Nishiwaki C; Ishida H; Nagamatsu S
Biochem Biophys Res Commun; 2003 Jul; 306(4):832-6. PubMed ID: 12821117
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice and beagle dogs.
Kasai S; Inoue T; Yoshitomi H; Hihara T; Matsuura F; Harada H; Shinoda M; Tanaka I
J Pharmacol Sci; 2008 Sep; 108(1):40-8. PubMed ID: 18776709
[TBL] [Abstract][Full Text] [Related]
13. Impact of increased PPARgamma activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment.
Takasawa K; Kubota N; Terauchi Y; Kadowaki T
Endocr J; 2008 Aug; 55(4):767-76. PubMed ID: 18506083
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of PPARγ specifically in pancreatic β-cells exacerbates obesity-induced glucose intolerance, reduces β-cell mass, and alters islet lipid metabolism in male mice.
Hogh KL; Craig MN; Uy CE; Nygren H; Asadi A; Speck M; Fraser JD; Rudecki AP; Baker RK; Orešič M; Gray SL
Endocrinology; 2014 Oct; 155(10):3843-52. PubMed ID: 25051434
[TBL] [Abstract][Full Text] [Related]
15. Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor γ Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice.
Ochiai M; Takeuchi T; Nozaki T; Ishihara KO; Matsuo T
J Food Sci; 2019 Feb; 84(2):339-348. PubMed ID: 30726580
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells.
Saitoh Y; Chun-ping C; Noma K; Ueno H; Mizuta M; Nakazato M
Diabetes Obes Metab; 2008 Jul; 10(7):564-73. PubMed ID: 17593232
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells.
Ravnskjaer K; Boergesen M; Rubi B; Larsen JK; Nielsen T; Fridriksson J; Maechler P; Mandrup S
Endocrinology; 2005 Aug; 146(8):3266-76. PubMed ID: 15878969
[TBL] [Abstract][Full Text] [Related]
18. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.
Hevener AL; Olefsky JM; Reichart D; Nguyen MT; Bandyopadyhay G; Leung HY; Watt MJ; Benner C; Febbraio MA; Nguyen AK; Folian B; Subramaniam S; Gonzalez FJ; Glass CK; Ricote M
J Clin Invest; 2007 Jun; 117(6):1658-69. PubMed ID: 17525798
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets.
Lalloyer F; Vandewalle B; Percevault F; Torpier G; Kerr-Conte J; Oosterveer M; Paumelle R; Fruchart JC; Kuipers F; Pattou F; Fiévet C; Staels B
Diabetes; 2006 Jun; 55(6):1605-13. PubMed ID: 16731822
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
